glp 1 court case Judicial Panel Authorizes New GLP-1 Vision Loss Litigation Disappointing GLP-1 Results in Alzheimer's

[100] In addition to the above controversies presented in PubMed by different research groups, a fundamental question that remains to be addressed is: although GLP-1 or GLP-1RAs may get access to the brain via a rapid and passive receptor-independent mechanism, [88,89] or by a receptor-mediated event, [95] does such access physiologically and pharmacologically relevant to their brain functions

Injectable semaglutide achieves roughly 89% bioavailability

Patel V, Joharapurkar A, Dhanesha N, Kshirsagar S, Patel K, Bahekar R, et al

Eroglu TE, Coronel R, Folke F, Gislason GJRP

Doctors should increase doses only after confirming the patient's tolerance without major gastrointestinal effects [10]